Duchenne Muscular Dystrophy Drugs Market Size, Share, Trends, and Forecasted Growth for 2026-2037
The global duchenne muscular dystrophy drugs market represents one of the most rapidly evolving segments within the rare disease and neuromuscular therapeutics space. The market was valued at USD 32.91 billion in 2025 and is expected to reach USD 66.56 billion by the end of 2037, expanding at a compound annual growth rate (CAGR) of 5.8% during the forecast period from 2026 to 2037.
This steady...
0 Condivisioni
30 Visualizzazioni